2021 FDA Zovomerezeka Zatsopano Zamankhwala 1Q-3Q

Zatsopano zimathandizira kupita patsogolo.Zikafika pazatsopano pakupanga mankhwala atsopano ndi mankhwala achire, FDA's Center for Drug Evaluation and Research (CDER) imathandizira makampani opanga mankhwala panjira iliyonse.Ndi kumvetsetsa kwake kwa sayansi yomwe imagwiritsidwa ntchito popanga zinthu zatsopano, kuyesa ndi kupanga njira, ndi matenda ndi mikhalidwe yomwe mankhwala atsopano amapangidwira, CDER imapereka upangiri wasayansi ndi malamulo ofunikira kuti abweretse mankhwala atsopano pamsika.
Kupezeka kwa mankhwala atsopano ndi zinthu zachilengedwe nthawi zambiri kumatanthauza njira zatsopano zothandizira odwala komanso kupita patsogolo kwa chithandizo chamankhwala kwa anthu aku America.Pachifukwa ichi, CDER imathandizira zatsopano ndipo imathandizira kupititsa patsogolo chitukuko chatsopano chamankhwala.
Chaka chilichonse, CDER imavomereza mitundu ingapo yamankhwala atsopano ndi zinthu zachilengedwe:
1. Zina mwazinthuzi ndi zatsopano zomwe sizinagwiritsidwepo ntchito pazachipatala.Pansipa pali mndandanda wazinthu zatsopano zamamolekyu ndi zinthu zatsopano zochizira zamankhwala zovomerezedwa ndi CDER mu 2021. M'ndandandawu mulibe katemera, zinthu zomwe sizingawope, magazi ndi zinthu zamagazi, zotuluka m'madzi a m'magazi, ma cellular ndi ma gene therapy, kapena zinthu zina zovomerezeka mu 2021 ndi Center for Biologics Evaluation and Research.
2. Zina ndizofanana, kapena zokhudzana ndi zinthu zomwe zidavomerezedwa kale, ndipo amapikisana ndi malondawo pamsika.Onani Drugs@FDA kuti mudziwe zambiri zamankhwala ovomerezeka a CDER ndi zinthu zachilengedwe.
Mankhwala ena amasankhidwa kukhala magulu atsopano a mamolekyu ("NMEs") pofuna kuwunikanso ndi FDA.Zambiri mwazinthuzi zimakhala ndi zigawo zogwira ntchito zomwe sizinavomerezedwe ndi FDA kale, kaya ngati mankhwala amodzi kapena ngati gawo la mankhwala osakaniza;mankhwalawa nthawi zambiri amapereka zofunika zatsopano mankhwala kwa odwala.Mankhwala ena amadziwika kuti ndi ma NME pazolinga zoyang'anira, komabe amakhala ndi magawo omwe amagwirizana kwambiri ndi zinthu zomwe zidavomerezedwa kale ndi FDA.Mwachitsanzo, CDER imayika m'magulu azinthu zachilengedwe zomwe zatumizidwa pansi pa ndime 351 (a) ya Public Health Service Act ngati ma NME pofuna kuwunikanso ndi FDA, mosasamala kanthu kuti bungweli lidavomerezapo kale gawo logwirizana ndi chinthu china.Magulu a FDA a mankhwala ngati "NME" kuti awonedwenso ndizosiyana ndi zomwe FDA imatsimikiza ngati mankhwala ndi "mankhwala atsopano" kapena "NCE" mu tanthauzo la Federal Food, Drug, and Cosmetic Act.

Ayi. Dzina la Mankhwala Yogwira pophika Tsiku Lovomerezeka Kugwiritsa ntchito kovomerezeka ndi FDA pa tsiku lovomerezeka *
37 Exkivity mobocertinib 9/15/2021 Kuchiza khansa ya m'mapapo yotsogola kwanuko kapena ya metastatic yomwe si yaing'ono yama cell ndi epidermal growth factor receptor exon 20 insertion masinthidwe
36 Skytrofa lonapegsomatropin-tcgd 8/25/2021 Kuchiza zazifupi chifukwa cha kusakwanira katulutsidwe ka endogenous growth hormone
35 Korsuva amafanana 8/23/2021 Kuchiza pruritus yokhazikika mpaka yowopsa yokhudzana ndi matenda a impso m'magulu ena
34 Welireg belzutifan 8/13/2021 Kuchiza matenda a von Hippel-Lindau pansi pazifukwa zina
33 Nexviazyme avalglucosidase alfa-ngpt 8/6/2021 Kuchiza matenda a Pompe mochedwa
Cholengeza munkhani
32 Saphnelo anifrolumab-fnia 7/30/2021 Kuchiza zolimbitsa thupi mpaka zowopsa za systemic lupus erythematousus limodzi ndi chithandizo chokhazikika
31 Bylvay odevixibat 7/20/2021 Kuchiza pruritus
30 Rezurock belumosudil 7/16/2021 Kuchiza matenda osatha kumezetsa-kuyerekeza ndi omwe akudwala pambuyo pakulephera kwa mizere iwiri yam'mbuyomu yamankhwala
29 fexidazole fexidazole 7/16/2021 Kuchiza anthu African trypanosomiasis chifukwa tizilombo Trypanosoma brucei gambinse
28 Kerendia finerenone 7/9/2021 Kuchepetsa chiopsezo cha zovuta za impso ndi mtima mu matenda a impso osatha omwe amakhudzana ndi matenda amtundu wa 2
27 Rylaze asparaginase erwinia chrysanthemi (recombinant) -rywn 6/30/2021 Kuchiza pachimake lymphoblastic khansa ya m'magazi ndi lymphoblastic lymphoma odwala amene sagwirizana ndi E. coli-derived asparaginase mankhwala, monga chigawo chimodzi cha mankhwala amphamvu.
Cholengeza munkhani
26 Aduhelm aducanumab-avwa 6/7/2021 Kuchiza matenda a Alzheimer's
Cholengeza munkhani
25 Brexafemme ibrexafuningerp 6/1/2021 Kuchiza vulvovaginal candidiasis
24 Lybalvi olanzapine ndi samidorphan 28/5/2021 Kuchiza schizophrenia ndi zina za bipolar I matenda
23 Truseltiq infigratinib 28/5/2021 Kuchiza cholangiocarcinoma amene matenda akwaniritsa zofunika zina
22 Lumakras sotorasib 28/5/2021 Kuchiza mitundu ya khansa ya m'mapapo yosakhala yaying'ono
Cholengeza munkhani
21 Pylarify piflufolastat F18 26/5/2021 Kuzindikira zotupa za prostate-specific membrane antigen-positive mu khansa ya prostate
20 Rybrevant amivantamab-vmjw 5/21/2021 Kuchiza kagawo kakang'ono ka khansa ya m'mapapo yosakhala yaying'ono
Cholengeza munkhani
19 Mverani pegcetacoplan 5/14/2021 Kuchiza paroxysmal nocturnal hemoglobinuria
18 Zynlonta loncastuximab tesirine-lpyl 23/4/2021 Kuchiza mitundu ina ya kubwereranso kapena refractory lalikulu B-cell lymphoma
17 Jemperli dostarlimab-gxly 22/4/2021 Kuchiza khansa ya endometrial
Cholengeza munkhani
16 Nextstellis drospirenone ndi estetrol 4/15/2021 Kupewa mimba
15 Qelbree viloxazine 4/2/2021 Kuchiza chidwi cha deficit hyperactivity disorder
14 Zegalogue dasiglucagon 3/22/2021 Kuchiza kwambiri hypoglycemia
13 Ponvory ponesimod 3/18/2021 Kuchiza mitundu yobwereranso ya multiple sclerosis
12 Fotivda tivozanib 3/10/2021 Kuchiza renal cell carcinoma
11 Azstarys serdexmethylphenidate ndi 3/2/2021 Kuchiza chidwi cha deficit hyperactivity disorder
dexmethylphenidate
10 Pepaxto melphalan flufenamide 2/26/2021 Kuchiza myeloma yobwerera m'mbuyo kapena refractory
9 Nulibry fosdenopterine 2/26/2021 Kuchepetsa chiopsezo cha kufa kwa molybdenum cofactor Type A
Cholengeza munkhani
8 Amondi 45 casimersen 2/25/2021 Kuchiza Duchenne muscular dystrophy
Cholengeza munkhani
7 Kosela trilacicilib 2/12/2021 Kuchepetsa chemotherapy-induced myelosuppression mu kansa yaing'ono ya m'mapapo
Cholengeza munkhani
6 Evkeeza evinacumab-dgnb 2/11/2021 Kuchiza homozygous Famer hypercholesterolemia
5 Ukoniq chimbale 2/5/2021 Kuchiza marginal zone lymphoma ndi follicular lymphoma
4 Tepmetko tepotinib 2/3/2021 Kuchiza khansa ya m'mapapo yosakhala yaying'ono
3 Lupkynis voclosporin 1/22/2021 Kuchiza lupus nephritis
Mayesero a Mankhwala Chithunzithunzi
2 Cabenuva cabotegravir ndi rilpivirine (zophatikizidwa) 1/21/2021 Kuchiza HIV
Cholengeza munkhani
Mayesero a Mankhwala Chithunzithunzi
1 Verquvo vericiguat 1/19/2021 Kuchepetsa chiopsezo cha kufa kwa mtima ndi kugonekedwa m'chipatala chifukwa cha kulephera kwa mtima kosatha
Mayesero a Mankhwala Chithunzithunzi

 

Zomwe zalembedwa "zovomerezeka ndi FDA" patsamba lino ndizongowonetsera zokha.Kuti muwone zovomerezeka ndi FDA zogwiritsira ntchito [mwachitsanzo, zizindikiro, anthu, chiwerengero cha anthu), ndondomeko ya mlingo pa chilichonse mwazinthuzi, onani Chidziwitso Chaposachedwa Chovomerezedwa ndi FDA.
Tchulani kuchokera patsamba la FDA:https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021


Nthawi yotumiza: Sep-27-2021